Free Account Opening + AMC Free Demat
Loading...

Glenmark Life Sciences IPO vs Paytm IPO

Comparision between Glenmark Life Sciences IPO and Paytm IPO.

IPO Details

Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Paytm IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Paytm IPO is up to ₹18,300.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Paytm IPO is ₹2,150.00 per share.

  Glenmark Life Sciences IPO Paytm IPO
Face Value ₹2 per share ₹1 per share
Issue Price (Lower) ₹695.00 per share ₹2,080.00 per share
Issue Price (Upper) ₹720.00 per share ₹2,150.00 per share
Issue Price (Final) ₹720.00 per share ₹2,150.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 20 shares 6 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,060.00 Cr up to ₹8,300.00 Cr
OFS Issue Size 63,00,000 shares
OFS Issue Size (Amount) up to ₹453.60 Cr up to ₹10,000.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,513.60 Cr up to ₹18,300.00 Cr

IPO Timetable

Glenmark Life Sciences IPO opens on Jul 27, 2021, while Paytm IPO opens on Nov 08, 2021. The closing date of Glenmark Life Sciences IPO and Paytm IPO is Jul 29, 2021, and Nov 10, 2021, respectively.

  Glenmark Life Sciences IPO Paytm IPO
Anchor Bid Date
Issue Open Jul 27, 2021 Nov 08, 2021
Issue Close Jul 29, 2021 Nov 10, 2021
Basis Of Allotment (Tentative) Aug 03, 2021 Nov 15, 2021
Initiation of Refunds (Tentative) Aug 04, 2021 Nov 16, 2021
Credit of Share (Tentative) Aug 05, 2021 Nov 17, 2021
Listing date (Tentative) Aug 06, 2021 Nov 18, 2021
Anchor Lockin End date 1 Sep 02, 2021 Dec 15, 2021
Anchor Lockin End date 2 Nov 01, 2021 Feb 13, 2022

Financials

Glenmark Life Sciences IPO P/E ratio is , as compared to Paytm IPO P/E ratio of .

  Glenmark Life Sciences IPO Paytm IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total Revenue 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
30-Jun-21 30-Jun-20 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 94,590 102,777 91,513 103,031 87,668
Total Revenue 9,480 6,494 31,868 35,407 35,797
Profit After Tax (3,819) (2,844) (17,010) (29,424) (42,309)
Promoter Shareholding (Pre-Issue) 100%
Promoter Shareholding (Post-Issue) 82.84%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Paytm IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 2,63,94,231 shares in Paytm IPO.

  Glenmark Life Sciences IPO Paytm IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 42,42,379 shares 2,63,94,231 shares
NII 32,32,770 shares 1,31,97,115 shares
RII 75,43,130 shares 87,98,076 shares
Employee 0 shares 0 shares
Others
Total 1,50,18,279 shares 4,83,89,422 shares

Bids Received (Subscription)

Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Paytm IPO subscribed 1.89x.

  Glenmark Life Sciences IPO Paytm IPO
QIB (times) 36.97x 2.79x
NII (times) 122.54x 0.24x
Big NII (times)
Small NII (times)
RII (times) 14.63x 1.66x
Employee (times)
Other (times)
Total (times) 44.17x 1.89x

Comments

Add a public comment...